Extended reality in medicine is not new. But it is now becoming visible.
A recent report by TechRadar on the use of Apple Vision Pro in ocular surgery has brought renewed attention to a practice that did not begin in 2026, but has been developing since at least late 2025.
The difference today is not the experiment, but its validation.
From testing to repeated practice
The procedure, led by Dr. Eric Rosenberg of SightMD in New England, uses the headset to provide:
- immersive stereoscopic 3D visualization
- real-time data access without breaking sterility
- the ability to collaborate remotely with other specialists
This is not an isolated case. Dr. Rosenberg has been using this system in multiple procedures since October 2025, marking a key shift: from one-off experimentation to continuous clinical use.
“It’s not just innovation, it’s access”
Beyond the technical breakthrough, the approach behind the system introduces a critical variable: cost.
In a LinkedIn post, Dr. Rosenberg stated:
“Very excited to bring this technology to surgeons all around the globe for less than it would cost to go to the movies. Not only do we have a game changing software that was built by an ophthalmologist for ophthalmologists, not only do we have Apple coding veterans of 30+ years, not only do we have the most robust full suite of dynamic options, but we also have a solution that isn’t going to make a resident or medical student decide between their education and eating for the day.”
The statement points to a meaningful shift in the XR narrative: from expensive technology to a potentially accessible clinical tool.
The role of clinical software
Another key differentiator is the focus on specialized software.
The system does not rely solely on hardware, but on a layer specifically developed for ophthalmology. This marks an evolution from earlier phases of XR in medicine, where technology was adapted to clinical environments rather than designed from within them.
XR in medicine: what is already clear
Without projecting future scenarios, current usage reveals clear trends:
From experiment to clinical tool
XR is already being used in real procedures, not just training.
From hardware to integrated solutions
The value lies in the integration between headset, software, and clinical workflow.
From high cost to more accessible models
Adoption will increasingly depend on affordability and accessibility.
From individual use to remote collaboration
Real-time assistance is reshaping how medical knowledge is shared.
Immersive surgery with Apple Vision Pro does not represent a starting point, but a point of visibility.
XR was already in the operating room.
Now it is being documented, repeated, and observed.
And that shift —from invisible to visible— is what ultimately defines when a technology moves from promise to consolidation.